Bensheim, Germany

Martin Schmidt

USPTO Granted Patents = 16 

 

 

Average Co-Inventor Count = 7.8

ph-index = 4

Forward Citations = 75(Granted Patents)


Location History:

  • Duisburg, DE (2012)
  • Benshelm, DE (2016)
  • Bensheim, DE (2000 - 2018)
  • Ludwigshafen, DE (2017 - 2020)

Company Filing History:


Years Active: 2000-2020

Loading Chart...
Loading Chart...
Loading Chart...
16 patents (USPTO):

Title: Innovations of Martin Schmidt

Introduction

Martin Schmidt, an accomplished inventor based in Bensheim, Germany, holds an impressive portfolio of 15 patents. His work primarily revolves around advancements in pharmaceutical compounds that target specific therapeutic areas.

Latest Patents

Schmidt's latest innovations include two significant patents: the first involves substituted isoxazolopyridazinones and isothiazolopyridazinones, which are described as compounds of formula (I) and their pharmaceutically acceptable salts. These compounds are reported to be useful in treating conditions or disorders that can be prevented or ameliorated by positive allosteric modulation of the gamma-aminobutyric acid B (GABA-B) receptor. The patent also details methods for creating these compounds and outlines pharmaceutical compositions and their applications.

The second innovative patent pertains to substituted pyrazolopyrimidines, again represented as compounds of formula (I) and their pharmaceutically acceptable salts. Similar to the first patent, these compounds are intended for treating conditions affected by the modulation of the GABA-B receptor. The methodologies for their synthesis and potential pharmaceutical use are also thoroughly described in this patent.

Career Highlights

Throughout his career, Martin Schmidt has collaborated with prominent companies in the pharmaceutical sector, including AbbVie Deutschland GmbH & Co. KG and AbbVie Inc. His contributions to these organizations have facilitated significant advancements in therapeutic drug development.

Collaborations

Schmidt has worked alongside notable colleagues such as Achim Moeller and Reinhold Mueller. Their teamwork has likely played a vital role in the research leading to the successful validation and patenting of new pharmaceutical compounds.

Conclusion

In summary, Martin Schmidt's innovative contributions to the field of pharmaceuticals, marked by his numerous patents, demonstrate his commitment to advancing medical science. His work plays a crucial role in the development of new therapies that can significantly improve patients' lives.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…